Detection, treatment, and prevention of carbapenemase-producing Enterobacteriaceae: recommendations from an International Working Group. (Q42258248)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Detection, treatment, and prevention of carbapenemase-producing Enterobacteriaceae: recommendations from an International Working Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Po-Ren Hsueh

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Gabriel Levy Hara

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Ian Gould

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Pilar Ramón Pardo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

George Daikos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Shaheen Mehtar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

George Petrikkos

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

José María Casellas

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Lucía Daciuk

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Daniela Paciel

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Andrea Novelli

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Raphael Saginur

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Daniel Pryluka

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Julio Medina

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Eduardo Savio

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

1 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

published in

Journal of Chemotherapy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

129-140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783137%20AND%20SRC:MED&resulttype=core&format=json

Carbapenems: past, present, and future

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

The continuing challenge of ESBLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Global spread of Carbapenemase-producing Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Carbapenem resistance in Enterobacteriaceae: here is the storm!

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Surveillance and management of multidrug-resistant microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Metallo-beta-lactamases in Gram-negative bacteria: introducing the era of pan-resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Carbapenemases: the versatile beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Evaluation of updated interpretative criteria for categorizing Klebsiella pneumoniae with reduced carbapenem susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Carbapenemases: a brief review for pediatric infectious disease specialists

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

The emerging NDM carbapenemases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

OXA-48-like carbapenemases: the phantom menace

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Escherichia coli from Italy producing OXA-48 carbapenemase encoded by a novel Tn1999 transposon derivative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Ertapenem resistance of Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Evaluation of different laboratory tests for the detection of metallo-beta-lactamase production in Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Evaluation of boronic acid disk tests for differentiating KPC-possessing Klebsiella pneumoniae isolates in the clinical laboratory

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Sensitive screening tests for suspected class A carbapenemase production in species of Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Detecting VIM-1 production in Proteus mirabilis by an imipenem-dipicolinic acid double disk synergy test

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Comparative evaluation of a chromogenic agar medium, the modified Hodge test, and a battery of meropenem-inhibitor discs for detection of carbapenemase activity in Enterobacteriaceae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Evaluation of CHROMagar KPC for rapid detection of carbapenem-resistant Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Detection of carbapenemase producers in Enterobacteriaceae by use of a novel screening medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Evaluation of the New NucliSENS EasyQ KPC test for rapid detection of Klebsiella pneumoniae carbapenemase genes (blaKPC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Detection of carbapenemases in Enterobacteriaceae by a commercial multiplex PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Evaluation of a commercial microarray system for detection of SHV-, TEM-, CTX-M-, and KPC-type beta-lactamase genes in Gram-negative isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Multicenter evaluation of a new DNA microarray for rapid detection of clinically relevant bla genes from beta-lactam-resistant gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Emergence of Klebsiella pneumoniae carbapenemase-producing bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Recognition and prevention of multidrug-resistant Gram-negative bacteria in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Colistin-resistant, Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae belonging to the international epidemic clone ST258.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Outbreak of KPC-3-producing, and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Nephrotoxicity of colistin: new insight into an old antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Serum bactericidal activity of three different dosing regimens of colistin with implications for optimum clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Dosing of colistin-back to basic PK/PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Pharmacological rationale for antibiotic treatment of intra-abdominal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Pharmacological and patient-specific response determinants in patients with hospital-acquired pneumonia treated with tigecycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Therapy of 1,025 severely ill patients with complicated infections in a German multicenter study: safety profile and efficacy of tigecycline in different treatment modalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Use of Monte Carlo Simulation to Design an Optimized Pharmacodynamic Dosing Strategy for Meropenem

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

In Vitro Evaluation of Antibiotic Synergy for Polymyxin B-Resistant Carbapenemase-Producing Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Fecal carriage of carbapenemase-producing Enterobacteriaceae: a hidden reservoir in hospitalized and nonhospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

A multifaceted intervention strategy for eradication of a hospital-wide outbreak caused by carbapenem-resistant Klebsiella pneumoniae in Southern Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

An effective intervention to limit the spread of an epidemic carbapenem-resistant Klebsiella pneumoniae strain in an acute care setting: from theory to practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Escherichia coli and Klebsiella pneumoniae carbapenemase in long-term care facility, Illinois, USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Comparison of disk diffusion, Etest and VITEK2 for detection of carbapenemase‐producing Klebsiella pneumoniae with the EUCAST and CLSI breakpoint systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

Evaluation of a DNA microarray for the rapid detection of extended-spectrum -lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and N

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1973947812Y.0000000062

10.1179/1973947812Y.0000000062

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783137%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference